Advances in airway clearance technologies for chronic obstructive pulmonary disease

References

• Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2013).
   Web of Science ®Google Scholar
• Lopez AD, Shibuya K, Rao C et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 27(2), 397–412 (2006).
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2013). Global Initiative for Chronic Obstructive Lung Disease, Inc. (2013).
   Google Scholar
• Kim V, Garfield JL, Grabianowski CL et al. The effect of chronic sputum production on respiratory symptoms in severe COPD. COPD 8(2), 114–120 (2011).
   PubMedGoogle Scholar
• Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67(5), 495–501 (2000).
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157(5 Pt 1), 1418–1422 (1998).
   PubMed Web of Science ®Google Scholar
• Burgel PR, Nesme-Meyer P, Chanez P et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 135(4), 975–982 (2009).
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir. Res. 6, 98 (2005).
   PubMed Web of Science ®Google Scholar
• Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 45(8), 579–585 (1990).
   PubMed Web of Science ®Google Scholar
• Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 130(4), 1129–1137 (2006).
   PubMed Web of Science ®Google Scholar
• Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur. Respir. J. 8(8), 1333–1338 (1995).
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am. J. Respir. Crit. Care Med. 153(5), 1530–1535 (1996).
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PM, Celli B et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 11, 122 (2010).
   PubMed Web of Science ®Google Scholar
• Lu M, Yao W, Zhong N et al. Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology 15(7), 1072–1078 (2010).
   PubMed Web of Science ®Google Scholar
• Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 166(3), 329–332 (2002).
   PubMed Web of Science ®Google Scholar
• De Oca MM, Halbert RJ, Lopez MV et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur. Respir. J. 40(1), 28–36 (2012).
   PubMed Web of Science ®Google Scholar
• Kim V, Han MK, Vance GB et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 140(3), 626–633 (2011).
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 106(2), 196–204 (1987).
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. National Clinical Guideline Centre, London, UK (2010).
   Google Scholar
• Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23(6), 932–946 (2004).
   PubMed Web of Science ®Google Scholar
• McKenzie DK, Abramson M, Crockett AJ et al.; The Australian Lung Foundation. The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease V2.30, 2011 (2011).
   Google Scholar
• Poole P, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (2), CD001287 (2010).
   Google Scholar
• Boe J, Dennis JH, O'driscoll BR et al. European Respiratory Society Guidelines on the use of nebulizers. Eur. Respir. J. 18(1), 228–242 (2001).
   PubMed Web of Science ®Google Scholar
• Poole PJ, Brodie SM, Stewart JM, Black PN. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD). Aust. NZ J. Med. 28(3), 322–326 (1998).
   PubMedGoogle Scholar
• Ram FS, Sestini P. Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Thorax 58(7), 580–584 (2003).
   PubMed Web of Science ®Google Scholar
• Osadnik C, Stuart-Andrews C, Ellis S, Thompson B, McDonald CF, Holland AE. Positive expiratory pressure via mask does not improve ventilation inhomogeneity more than huffing and coughing in individuals with stable chronic obstructive pulmonary disease and chronic sputum expectoration. Respiration doi:10.1159/000348546 (2013) ( Epub ahead of print).
   Google Scholar
• Kim CS, Greene MA, Sankaran S, Sackner MA. Mucus transport in the airways by two-phase gas-liquid flow mechanism: continuous flow model. J. Appl. Physiol. 60(3), 908–917 (1986).
   PubMed Web of Science ®Google Scholar
• Fagevik Olsen M, Westerdahl E. Positive expiratory pressure in patients with chronic obstructive pulmonary disease - a systematic review. Respiration 77(1), 110–118 (2009).
   PubMed Web of Science ®Google Scholar
• Falk M, Kelstrup M, Andersen JB et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur. J. Respir. Dis. 65(6), 423–432 (1984).
   PubMedGoogle Scholar
• Oberwaldner B, Evans JC, Zach MS. Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr. Pulmonol. 2(6), 358–367 (1986).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Conoscenti CC, Menashe P, Nair S. Noninvasive face mask ventilation in patients with acute respiratory failure. Chest 95(4), 865–870 (1989).
   PubMed Web of Science ®Google Scholar
• Andersen JB, Qvist J, Kann T. Recruiting collapsed lung through collateral channels with positive end-expiratory pressure. Scand. J. Respir. Dis. 60(5), 260–266 (1979).
   PubMedGoogle Scholar
• Groth S, Stafanger G, Dirksen H, Andersen JB, Falk M, Kelstrup M. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull. Eur. Physiopathol. Respir. 21(4), 339–343 (1985).
   PubMedGoogle Scholar
• Hill K, Patman S, Brooks D. Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Chron. Respir. Dis. 7(1), 9–17 (2010).
   PubMedGoogle Scholar
• Ides K, Vissers D, De Backer L, Leemans G, De Backer W. Airway clearance in COPD: need for a breath of fresh air? A systematic review. COPD 8(3), 196–205 (2011).
   PubMedGoogle Scholar
• Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst. Rev. (4), CD000045 (1998).
   Google Scholar
• Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 3, CD008328 (2012).
   PubMed Web of Science ®Google Scholar
• Tang CY, Taylor NF, Blackstock FC. Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy 96(1), 1–13 (2010).
   PubMed Web of Science ®Google Scholar
• Nowobilski R, Wloch T, Plaszewski M, Szczeklik A. Efficacy of physical therapy methods in airway clearance in patients with chronic obstructive pulmonary disease: a critical review. Pol. Arch. Med. Wewn. 120(11), 468–477 (2010).
   PubMed Web of Science ®Google Scholar
• Bellone A, Spagnolatti L, Massobrio M et al. Short-term effects of expiration under positive pressure in patients with acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non-invasive positive pressure ventilation. Intensive Care. Med. 28(5), 581–585 (2002).
   PubMed Web of Science ®Google Scholar
• Vargas F, Bui HN, Boyer A et al. Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [ISRCTN17802078]. Crit. Care 9(4), R382–389 (2005).
   Web of Science ®Google Scholar
• Lee AL, Burge A, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst. Rev. 5, CD008351 (2013).
   Google Scholar
• Cross J, Elender F, Barton G et al. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Health Technol. Assess. 14(23), 1–147, iii–iv (2010).
   PubMed Web of Science ®Google Scholar
• Osadnik CR, Mcdonald CF, Miller BR et al. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. Thorax doi:10.1136/thoraxjnl-2013-203425 (2013) ( Epub ahead of print).
   Google Scholar
• Bott J, Blumenthal S, Buxton M et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 64( Suppl. 64), i1–51 (2009).
   PubMed Web of Science ®Google Scholar
• Langer D, Hendriks E, Burtin C et al. A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin. Rehabil. 23(5), 445–462 (2009).
   PubMed Web of Science ®Google Scholar
• Ewart W. The treatment of bronchiectasis and of chronic bronchial affections by posture and by respiratory exercises. Lancet 2, 70–72 (1901).
   Google Scholar
• MacMahon C. Breathing and physical exercises for use in cases of wounds in the pleura, lung and diaphragm. Lancet 2, 769–770 (1915).
   Google Scholar
• Osadnik CR, McDonald CF, Holland AE. Airway clearance techniques in acute exacerbations of COPD: a survey of Australian physiotherapy practice. Physiotherapy 99(2), 101–106 (2013).
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Connolly MJ. A national survey: percussion, vibration, shaking and active cycle breathing techniques used in patients with acute exacerbations of chronic obstructive pulmonary disease. Physiotherapy 93(2), 110–113 (2007).
   Web of Science ®Google Scholar
• Harth L, Stuart J, Montgomery C et al. Physical therapy practice patterns in acute exacerbations of chronic obstructive pulmonary disease. Can. Respir. J. 16(3), 86–92 (2009).
   PubMed Web of Science ®Google Scholar
• Lee A, Button B, Denehy L. Current Australian and New Zealand physiotherapy practice in the management of patients with bronchiectasis and chronic obstructive pulmonary disease. NZ J. Physiother. 36(2), 49–58 (2008).
   Google Scholar
• Ragavan AJ. Comparing performance of three oscillating positive expiratory pressure devices at similar amplitude and frequencies of oscillations on displacement of mucus inside trachea during cough. Respir. Care doi:10.4187/respcare.01631 (2012) ( Epub ahead of print).
   Google Scholar
• Cegla UH, Jost HJ, Harten A, Weber T, Wissmann S. (Course of severe COPD with and without physiotherapy with the RC-Cornet) [German]. Pneumologie 56(7), 418–424 (2002).
   PubMedGoogle Scholar
• Cegla UH, Jost JH, Harten A, Weber T. RC-Cornet improves the bronchodilating effect of ipratropiumbromide (Atrovent) inhalation in COPD-patients. Pneumologie 55(10), 465–469 (2001).
   PubMedGoogle Scholar
• Christensen EF, Dahl R. Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure. Lung 169(6), 325–333 (1991).
   PubMed Web of Science ®Google Scholar
• Christensen EF, Norregaard O, Dahl R. Nebulized terbutaline and positive expiratory pressure in chronic obstructive pulmonary disease. Pneumologie 45(3), 105–109 (1991).
   PubMedGoogle Scholar
• Wolkove N, Baltzan MA Jr, Kamel H, Rotaple M. A randomized trial to evaluate the sustained efficacy of a mucus clearance device in ambulatory patients with chronic obstructive pulmonary disease. Can. Res. J. 11(8), 567–572 (2004).
   PubMedGoogle Scholar
• Wolkove N, Kamel H, Rotaple M, Baltzan MA Jr. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. Chest 121(3), 702–707 (2002).
   PubMed Web of Science ®Google Scholar
• Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest 96(6), 1241–1246 (1989).
   PubMed Web of Science ®Google Scholar
• Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst. Rev. (2), CD000052 (2006).
   Google Scholar
• Mandelberg A, Chen E, Noviski N, Priel IE. Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler. Chest 112(6), 1501–1505 (1997).
   PubMed Web of Science ®Google Scholar
• Dwyer TJ, Alison JA, Mckeough ZJ, Daviskas E, Bye PT. Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis. Chest 139(4), 870–877 (2011).
   PubMed Web of Science ®Google Scholar
• Oldenburg FA Jr, Dolovich MB, Montgomery JM, Newhouse MT. Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Am. Rev. Respir. Dis. 120(4), 739–745 (1979).
   PubMed Web of Science ®Google Scholar
• Griffiths TL, Burr ML, Campbell IA et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355(9201), 362–368 (2000).
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (4), CD003793 (2006).
   Google Scholar
• Nici L, Donner C, Wouters E et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 173(12), 1390–1413 (2006).
   PubMed Web of Science ®Google Scholar
• Ries AL, Bauldoff GS, Carlin BW et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 131( 5 Suppl.), 4S–42S (2007).
   PubMed Web of Science ®Google Scholar
• Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (10), CD005305 (2011).
   Google Scholar
• Kirsten DK, Taube C, Lehnigk B, Jorres RA, Magnussen H. Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir. Med. 92(10), 1191–1198 (1998).
   PubMed Web of Science ®Google Scholar
• Tang CY, Blackstock FC, Clarence M, Taylor NF. Early rehabilitation exercise program for inpatients during an acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. J. Cardiopulm. Rehabil. Prev. 32(3), 163–169 (2012).
   PubMed Web of Science ®Google Scholar
• Troosters T, Probst VS, Crul T et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181(10), 1072–1077 (2010).
   PubMed Web of Science ®Google Scholar
• Eaton T, Young P, Fergusson W et al. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology 14(2), 230–238 (2009).
   PubMed Web of Science ®Google Scholar
• Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch. Phys. Med. Rehabil. 79(7), 849–854 (1998).
   PubMed Web of Science ®Google Scholar
• Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (3), CD004104 (2004).
   Google Scholar
• Nava S, Barbarito N, Piaggi G, De Mattia E, Cirio S. Physiological response to intrapulmonary percussive ventilation in stable COPD patients. Respir. Med. 100(9), 1526–1533 (2006).
   PubMed Web of Science ®Google Scholar
• Ides K, Vos W, De Backer L et al. Acute effects of intrapulmonary percussive ventilation in COPD patients assessed by using conventional outcome parameters and a novel computational fluid dynamics technique. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 667–671 (2012).
   PubMed Web of Science ®Google Scholar
• Oostveen E, Macleod D, Lorino H et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur. Respir. J. 22(6), 1026–1041 (2003).
   PubMed Web of Science ®Google Scholar
• Borrill ZL, Roy K, Vessey RS, Woodcock AA, Singh D. Non-invasive biomarkers and pulmonary function in smokers. Int. J. Chron. Obstruct. Pulmon. Dis. 3(1), 171–183 (2008).
   PubMedGoogle Scholar
• Tufvesson E, Aronsson D, Ankerst J, George SC, Bjermer L. Peripheral nitric oxide is increased in rhinitic patients with asthma compared to bronchial hyperresponsiveness. Respir. Med. 101(11), 2321–2326 (2007).
   PubMed Web of Science ®Google Scholar
• Timmins SC, Diba C, Farrow CE et al. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest 142(2), 312–319 (2012).
   PubMed Web of Science ®Google Scholar
• Hira H, Munjal J, Zachariah S, Chauhan M, Singh A. The site of airway obstruction among patients of emphysema: role of impulse oscillometry. Lung India 25(1), 8–13 (2008).
   PubMedGoogle Scholar
• Aronsson D, Tufvesson E, Ankerst J, Bjermer L. Allergic rhinitis with hyper-responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test. Clin. Physiol. Funct. Imaging 28(2), 81–85 (2008).
   PubMed Web of Science ®Google Scholar
• Barua M, Nazeran H, Nava P, Granda V, Diong B. Classification of pulmonary diseases based on impulse oscillometric measurements of lung function using neural networks. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5, 3848–3851 (2004).
   Google Scholar
• Nelson HS, Gallegos CM, Silveira LJ, Newell JD, Gelfand EW. Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. Allergy Asthma Proc. 30(3), 284–292 (2009).
   PubMed Web of Science ®Google Scholar
• Langley SJ, Houghton CM, Singh SD. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients. Respiration 72( Suppl. 72), 35–37 (2005).
   PubMed Web of Science ®Google Scholar
• Figueiredo PH, Zin WA, Guimaraes FS. Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother. Res. Int. 17(1), 12–20 (2012).
   PubMedGoogle Scholar
• Verbanck S. Physiological measurement of the small airways. Respiration 84(3), 177–188 (2012).
   PubMed Web of Science ®Google Scholar
• Robinson PD, Latzin P, Verbanck S et al. Consensus statement for inert gas washout measurement using multiple and single breath tests. Eur. Respir. J. 41(3), 507–522 (2013).
   PubMed Web of Science ®Google Scholar
• Haidl P, Rickert G, Cegla UH, Kohler D. Influence of an oscillating physiotherapy device (RC-Cornet trade mark) on the regional distribution of the pulmonary aerosol deposition in patients with COPD. Pneumologie 56(8), 498–502 (2002).
   PubMedGoogle Scholar
• Pavia D, Thomson ML, Phillipakos D. A preliminary study of the effect of a vibrating pad on bronchial clearance. Am. Rev. Respir. Dis. 113(1), 92–96 (1976).
   PubMedGoogle Scholar
• Van Hengstum M, Festen J, Beurskens C, Hankel M, Beekman F, Corstens F. Effect of positive expiratory pressure mask physiotherapy (PEP) versus forced expiration technique (FET/PD) on regional lung clearance in chronic bronchitics. Eur. Respir. J. 4(6), 651–654 (1991).
   PubMed Web of Science ®Google Scholar
• Van Hengstum M, Festen J, Beurskens C et al. The effect of positive expiratory pressure versus forced expiration technique on tracheobronchial clearance in chronic bronchitics. Scand. J. Gastroenterol. Suppl. 143, 114–118 (1988).
   PubMedGoogle Scholar
• Van Der Schans CP, Piers DA, Postma DS. Effect of manual percussion on tracheobronchial clearance in patients with chronic airflow obstruction and excessive tracheobronchial secretion. Thorax 41(6), 448–452 (1986).
   PubMed Web of Science ®Google Scholar
• Joosten S, Macdonald M, Lau KK, Bardin P, Hamilton G. Excessive dynamic airway collapse co-morbid with COPD diagnosed using 320-slice dynamic CT scanning technology. Thorax 67(1), 95–96 (2012).
   PubMed Web of Science ®Google Scholar
• Radford R, Barutt J, Billingsley J, Hill W, Lawson W, Willich W. A rational basis for percussion-augmented mucociliary clearance. Respir. Care 27(5), 556–563 (1982).
   Google Scholar
• Gross D, Zidulka A, O'brien C et al. Peripheral mucociliary clearance with high-frequency chest wall compression. J. Appl. Physiol. 58(4), 1157–1163 (1985).
   PubMed Web of Science ®Google Scholar
• Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 355(9219), 1931–1935 (2000).
   PubMed Web of Science ®Google Scholar
• Guerin C, Lemasson S, De Varax R, Milic-Emili J, Fournier G. Small airway closure and positive end-expiratory pressure in mechanically ventilated patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 155(6), 1949–1956 (1997).
   PubMed Web of Science ®Google Scholar
• Schwab RJ, Pack AI, Gupta KB et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am. J. Respir. Crit. Care Med. 154(4 Pt 1), 1106–1116 (1996).
   PubMed Web of Science ®Google Scholar
• Dellaca RL, Rotger M, Aliverti A, Navajas D, Pedotti A, Farre R. Noninvasive detection of expiratory flow limitation in COPD patients during nasal CPAP. Eur. Respir. J. 27(5), 983–991 (2006).
   PubMed Web of Science ®Google Scholar
• Lourens MS, Van Den Berg B, Verbraak AF, Hoogsteden HC, Bogaard JM. Effect of series of resistance levels on flow limitation in mechanically ventilated COPD patients. Respir. physiol. 127(1), 39–52 (2001).
   PubMedGoogle Scholar